The largest database of trusted experimental protocols

10 protocols using ab156046

1

Immunostaining of HEK-293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK-293 cultures expressing each chain individually were grown to confluency in Dulbecco’s modified Eagles medium (GIBCO) supplemented with 10% fetal calf serum (GIBCO) in 4-well chamber slides. Cells were incubated overnight in media supplemented with 0.25 mM sodium ascorbate to facilitate collagen biosynthesis. Cells were fixed in 2% paraformaldehyde, permeabilized with 0.1% v/v Triton-X100 (Sigma), and blocked with 10% normal goat serum (Abcam, ab156046) in 1× PBS. Primary and secondary antibodies were added at the same concentration and incubation times as for the immunohistochemical studies (see Table 1).
+ Open protocol
+ Expand
2

Whole-Tissue Fluorescent Staining of Cochleae

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the whole-tissue staining, we first removed cartilaginous capsule from the dissected cochleae and performed the fluorescence staining according to the previous study [51 (link)]. Briefly, the samples were fixed with 4% PFA in PBS overnight at 4°C and then blocked by incubation in 10% normal goat serum (Abcam, #ab156046) diluted in 0.1% Triton X-100/PBS (PBT) for 3 h at 37°C. The samples were treated with primary antibodies overnight at 4°C, washed in 0.1% PBT and subsequently treated with secondary antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 647 overnight at 4°C. DAPI (Dojindo Molecular Technologies, #D523-10, 1 : 200 dilution) was used for counterstaining of nucleus.
+ Open protocol
+ Expand
3

Immunohistochemistry of Epididymis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissected epididymides were fixed with 4% PFA in PBS for 2 h at 4°C or for 20 min at 37°C, or with 2% TCA in Ca2+- and Mg2+-free PBS for 20 min at 4°C, depending on target epitopes. The samples were then blocked by incubation in 10% normal goat serum (NGS) (Abcam, ab156046) or 10% normal donkey serum (Abcam, ab166643) diluted in 0.1% Triton X-100/PBS, depending on the secondary antibody species, for 3 h at 37°C. The samples were treated with primary antibodies overnight at 4°C, and subsequently incubated with secondary antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 647 (1:1000, Thermo Fisher Scientific) overnight at 4°C. We used TRITC-conjugated phalloidin (0.3 μg/ml, Merck Millipore, FAK100) and Hoechst 33342 (5 μg/ml, Thermo Fisher Scientific, H3570) for the visualization of F-actin and DNA, respectively.
+ Open protocol
+ Expand
4

c-Fos Immunohistochemistry in Tissue Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Experiment C, sections were removed from TSB, washed in PBS, and submerged in 20% goat serum (ab156046, Abcam) for 2 h at room temperature. The sections were then washed three times with PBS-0.1% Triton X-100 Detergent (PBS-T). Then, they were incubated with a primary antibody against c-Fos (rabbit, #2250, 1:400; Cell Signaling Technology) at 4°C overnight. Subsequently, the sections were washed three times using PBS-T and then incubated in a secondary anti-rabbit IgG antibody conjugated with AlexaFluor 488 (Goat, #111-545-003, 1:400; Jackson ImmunoResearch) for 2 h at room temperature. The sections were washed three times with PBS, and were mounted on glass slides and sealed with coverslips and ProLong Diamond antifade mounting medium containing DAPI, as in Experiment A.
+ Open protocol
+ Expand
5

Tracheae Staining and Optical Clearing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Staining and optical clearing of dissected tracheae were performed as described in a previous study (Hirashima and Adachi, 2015 (link)). Briefly, the samples were fixed with 4% PFA in PBS overnight at 4°C. For anti-SOX9 staining, the samples were incubated in 25 mg/mL hyaluronidase (Nacalai Tesque, #18240-36) for 1 h at 37°C, to digest hyaluronic acid. The samples were then blocked in 10% normal goat serum (Abcam, #ab156046) diluted in 0.1% Triton X-100/PBS (PBT) for 3 h at 37°C. The samples were treated with primary antibodies overnight at 4°C, washed in 0.1% PBT, and subsequently incubated in secondary antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 647 overnight at 4°C. DAPI was used for nuclear counterstaining (Dojindo Molecular Technologies, #D523-10, 1:200 dilution). The samples were mounted with 10 μL of 1% agarose gel onto a glass dish (Greiner Bio-One, #627871) for stable imaging. Then, the samples were immersed in CUBIC-R+ (Tokyo Chemical Industry Co., # T3741) solution for optical clearing. Images were acquired using the confocal laser scanning platform Leica TCS SP8 equipped with the hybrid detector Leica HyD, using a ×40 objective lens (NA = 1.3, WD = 240 μm, HC PL APO CS2, Leica) and the Olympus FluoView FV1000 with a ×30 objective lens (NA = 1.05, WD = 0.8 mm, UPLSAPO30XS, Olympus).
+ Open protocol
+ Expand
6

Macrophage Infiltration Analysis in PEG Hydrogel Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the macrophage infiltration following implantation with PEG hydrogels, paraffin-sectioned slides were stained for mouse CD-68 and CD-163. First, sections were deparaffinized with Xylene and rehydrated. Slides were incubated in peroxide blocking reagent (BUF017B, BioRad, USA) for 30 min at room temperature to block any endogenous peroxidase activity. The slides were then incubated in antigen retrieval buffer, pH8.0 (BUF025A, BioRad) for 20 min at 96 °C and additional 20 min at room temperature for antigen retrieval. Following which the slides were incubated with normal goat serum (ab156046, abcam, USA) to block non-specific binding sites for 30 minutes at room temperature. The sections were incubated overnight at 4 °C with primary antibodies: rat anti-mouse CD-68 antibody (1:100 dilution, MCA1957; BioRad), rabbit anti-mouse CD-163 antibody (1:100 dilution, ab182422, abcam). The slides were subsequently incubated for 60 minutes at room temperature with secondary antibodies: goat anti-rat (1:100 dilution, STAR72, BioRad) for CD-68 and goat anti-rabbit (1:500 dilution, ab97051, abcam) for CD-163. Diaminobenzidine (ab94665, abcam) was used as a chromogen and hematoxylin as a counterstain. For negative-controls, paraffin sections were incubated without the primary antibody.
+ Open protocol
+ Expand
7

BrdU Immunolocalisation in Carapace Epithelia

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU immunolocalisation was assayed in cultured intact carapace-epithelia (n = 5) following BrdU incorporation in vitro over 48 h in a 10 μM BrdU (ab142567; Abcam) labelling solution. The samples were prepared, fixed and permeabilised as described above for EdU incorporation, then incubated in 1 M HCl for 30 min at room temperature. The samples were then blocked in 5% normal goat serum (ab156046; Abcam) in PBS for 1 h, incubated in rabbit polyclonal anti-BrdU (1/100 dilution, Abcam, ab152095) overnight at 4°C and then rinsed three times in 1× PBS. After an incubation for 2 h in the dark at room temperature in goat anti-rabbit IgG H&L conjugated to Alexa Fluor 555 (1/1000 dilution, ab150086, Abcam), the samples were mounted in ProLong Gold Anti-fade mountant with DAPI (Thermo Fisher Scientific) and visualised using fluorescent microscopy. Percentage cell proliferation was quantified.
+ Open protocol
+ Expand
8

Cochlear Immunostaining and Optical Clearing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cochleae were gently freed from the capsule, and the staining and clearing were performed according to an earlier study (Hirashima and Adachi, 2015 (link)). Briefly, the samples were fixed with 4% PFA in PBS overnight at 4°C and then blocked by incubation in 10% normal goat serum (Abcam, #ab156046) diluted in 0.1% Triton X-100/PBS (PBT) for 3 hr at 37°C. The samples were treated with primary antibodies overnight at 4°C, washed in 0.1% PBT, and subsequently treated with secondary antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 647 overnight at 4°C. For counter staining of nucleus, we used DAPI (Dojindo Molecular Technologies, #D523-10, 1:200 dilution). The samples were mounted with 10 µL of 1% agarose gel onto a glass-based dish (Greiner Bio-One, #627871) for stable imaging. Then, the samples were immersed with the CUBIC-R+ (Tokyo Chemical Industry Co., #T3741) solution for optical clearing. Images were acquired using the confocal laser scanning platform Leica TCS SP8 equipped with the hybrid detector Leica HyD with the ×40 objective lens (NA = 1.3, WD = 240 μm, HC PL APO CS2, Leica) and the ×20 objective lens (NA = 0.75, WD = 680 µm, HC PL APO CS2, Leica) and the Olympus FluoView FV1000 with the ×30 objective lens (NA = 1.05, WD = 0.8 mm, UPLSAPO30XS, Olympus).
+ Open protocol
+ Expand
9

Cochlear Tissue Clearing and Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cochleae were gently freed from the capsule and the staining and clearing were performed according to an earlier study (Hirashima and Adachi, 2015) (link). Briefly, the samples were fixed with 4% PFA in PBS overnight at 4°C and then blocked by incubation in 10% normal goat serum (Abcam, #ab156046) diluted in 0.1% Triton X-100/PBS (PBT) for 3 h at 37°C. The samples were treated with primary antibodies overnight at 4°C, washed in 0.1% PBT, and subsequently treated with secondary antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 647 overnight at 4°C. For counter staining of nucleus, we mixed Hoechst 33342 (5 μg/ml, Dojindo Molecular Technologies, #H342-10) or DAPI (Dojindo Molecular Technologies, #D523-10, 1:200 dilution) . The samples were mounted with 10 µL of 1% agarose gel onto a glass-based dish (Greiner Bio-One, #627871) for stable imaging. Then, the samples were immersed with the BABB (benzyl-alcohol and benzyl-benzoate, 1:2, #04520-96 and # 04601-65, Nacalai Tesque) solution or CUBIC-R+ (Tokyo Chemical Industry Co., # T3741) solution for optical clearing. Images were acquired using the confocal laser scanning platform Leica TCS SP8 equipped with the hybrid detector Leica HyD with the ×40 objective lens (NA = 1.3, WD = 240 μm, HC PL APO CS2, Leica) and the Olympus FluoView FV1000 with the ×30 objective lens (NA = 1.05, WD = 0.8 mm, UPLSAPO30XS, Olympus).
+ Open protocol
+ Expand
10

Staining and Optical Clearing of Tracheae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Staining and optical clearing of dissected tracheae were performed as described in a previous study (Hirashima and Adachi, 2015) (link). Briefly, the samples were fixed with 4% PFA in PBS overnight at 4°C. For anti-SOX9 staining, the samples were incubated in 25 mg/mL hyaluronidase (Nacalai Tesque, #18240-36) for 1 h at 37°C, to digest hyaluronic acid. The samples were then blocked in 10% normal goat serum (Abcam, #ab156046) diluted in 0.1% Triton X-100/PBS (PBT) for 3 h at 37°C. The samples were treated with primary antibodies overnight at 4°C, washed in 0.1% PBT, and subsequently incubated in secondary antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 647 overnight at 4°C. DAPI was used for nuclear counterstaining (Dojindo Molecular Technologies, #D523-10, 1:200 dilution). The samples were mounted with 10 µL of 1% agarose gel onto a glass dish (Greiner Bio-One, #627871) for stable imaging. Then, the samples were immersed in CUBIC-R+ (Tokyo Chemical Industry Co., # T3741) solution for optical clearing. Images were acquired using the confocal laser scanning platform Leica TCS SP8 equipped with the hybrid detector Leica HyD, using a ×40 objective lens (NA = 1.3, WD = 240 μm, HC PL APO CS2, Leica) and the Olympus FluoView FV1000 with a ×30 objective lens (NA = 1.05, WD = 0.8 mm, UPLSAPO30XS, Olympus).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!